Bayer Aktiengesellschaft (BAYN.DE)
- Reuters
Bayer confirms 2024 outlook despite slow start for agriculture, consumer health units
FRANKFURT (Reuters) -Bayer confirmed its full-year forecast for earnings and cash flow on Monday despite slow business at its crop science and consumer health divisions. "Our Crop Science and Consumer Health divisions expect a slow start to the year due to market dynamics, but we feel confident in our full-year targets and the direction of our businesses," CEO Bill Anderson said in his speech for the April 26 annual general meeting (AGM), which was posted on the company's website on Monday. The CEO reiterated that 2024 earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-off items and currency swings, would decline between 3% and 9% and that free cash flow would reach 2-3 billion euros ($2.1-$3.2 billion) up from 1.3 billion last year.
- Fortune
Pharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion
Chief executive Bill Anderson says he doesn’t want it to be a "lame" company, but its stock has still tanked 50%.
- Benzinga
Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
On Tuesday, Bayer AG (OTC:BAYRY) and Alphabet Inc’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google Cloud announced a collaboration to develop artificial intelligence (AI) solutions to support radiologists. As part of the collaboration, Bayer will further develop its platform to accelerate the development and deployment of AI-powered healthcare applications with a clear focus on radiology, using Google Cloud’s technology, including its generative AI (gen AI) tools. The collaboration aims to help organizatio
